Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Event Logistics

Celgene building

Celgene to acquire biotech firm Quanticel Pharmaceuticals

Firm hopes to expand its pipeline of life-enhancing products for cancer patients

- PMLiVE

INC Research and DrugDev collaborate to push clinical trials

Aims to create cloud-based solutions to boost efficacy

- PMLiVE

Is a UK market access shake-up on the cards?

Former coalition government health minister Paul Burstow tells PMLiVE that NICE, QALY and broader issues of market access in England are all being put under review

Pharma deals in February 2015

Pfizer and Valeant led the way during a respectable, if not record-breaking, month for mergers, acquisitions and collaborations

Medius Deal Watch table for February 2015

The top major pharma mergers, acquisitions and collaborations during the month were led by the Pfizer/Hospira and Salix/Valeant deals

Bristol-Myers Squibb (BMS) building

BMS’ Opdivo backed as melanoma therapy in EU

First checkpoint inhibitor to be recommended for approval in the region

- PMLiVE

Cristal Therapeutics names chief business officer

Neuroscientist Jeroen Tonnaer to take up the position

- PMLiVE

Patient-centric strategies for emerging markets

Adopting an open and innovative mindset is key

- PMLiVE

Health wins big at second UK Blog Awards

Evidently Cochrane named Company Health Blog of the Year

- PMLiVE

Teva circling as Perrigo rejects second Mylan offer

Claims latest offer is lower than a recent informal bid

- PMLiVE

Clinigen acquires Idis for £225m

Acquisition makes them the global leader in unlicensed medicines

Roche Basel Switzerland

Roche maintains top place in biologic sales

But the looming threat of biosimilars is set to shake up the market

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links